MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation
Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation
Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation
Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation
Journal Article

Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation

2025
Request Book From Autostore and Choose the Collection Method
Overview
Oral squamous cell carcinoma (OSCC) urgently requires innovative therapeutic strategies due to its severity and stagnant five-year survival rate. Targeting glutamine metabolism, a promising approach, is hampered by tumor cells’ profound metabolic plasticity. Through a series of experiments, we uncovered heterogeneous responses of OSCC cell lines to glutamine deprivation: While most cells maintained growth, HSC3 cells showed a marked reduction in proliferation. Subsequent experiments have shown that this slowdown was not due to programmed cell death. Metabolomics and biochemical assays revealed elevated cholesterol ester (ChE) levels in glutamine-tolerant cells, not due to enhanced endogenous synthesis (HMGCS1/SQLE expression decreased) but via upregulated low-density lipoprotein receptor (LDLR)-mediated LDL uptake. Moreover, we found that fatty acid oxidation during glutamine deprivation not only supplied substrates for the tricarboxylic acid (TCA) cycle but also accelerated energy metabolism and potentially increased lipid synthesis for membrane structure and signaling. RNA sequencing identified robust enrichment of the peroxisome proliferator-activated receptor α (PPARα) pathway in tolerant cells. Reactive oxygen species (ROS) accumulation and activating transcription factor 5 (ATF5) nuclear translocation suggested the activation of multiple stress response pathways to maintain survival and growth under glutamine deprivation. Our study reveals a survival mechanism in OSCC: cells enhance exogenous lipid utilization to bypass glutamine dependence. Combined inhibition of LDL uptake and PPARα signaling may overcome metabolic plasticity, providing a rationale for precision therapies targeting metabolic heterogeneity in OSCC. Graphical abstract